Surgical treatment of active native mitral infective endocarditis: A meta-analysis of current evidence

Jian-Zhou Liu1, Xiao-Feng Li1, Qi Miao1

  • 1Department of Cardiac Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Abstract

Insights

Mitral valvuloplasty (MVP) may offer better survival outcomes than mitral valve replacement (MVR) for active native mitral infective endocarditis. This meta-analysis suggests MVP is a durable alternative, but further trials are needed.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Infectious Diseases

Background:

  • Active native mitral infective endocarditis (ANMIE) carries a poor prognosis without surgical intervention.
  • Both mitral valvuloplasty (MVP) and mitral valve replacement (MVR) are surgical options for ANMIE.
  • Comparative outcomes between MVP and MVR for ANMIE remain unclear.

Purpose of the Study:

  • To systematically review and compare the outcomes of MVP versus MVR in patients with ANMIE.
  • To evaluate mortality and survival rates as primary endpoints for both surgical approaches.

Main Methods:

  • A systematic literature review identified comparative observational studies on MVP versus MVR for ANMIE.
  • Data on patient characteristics, surgical methods, and follow-up were extracted.
  • Pooled odds ratios (OR) and hazard ratios (HR) were calculated to compare outcomes, with publication bias assessed.

Main Results:

  • Nine studies involving 633 patients (265 MVP, 368 MVR) were analyzed.
  • MVP was associated with significantly lower operative mortality (OR 0.37, p=0.0005).
  • MVP showed improved 1- and 5-year event-free survival (HR 0.43, p=0.03; HR 0.44, p=0.004) and overall survival (HR 0.55, p=0.004 at 5 years).

Conclusions:

  • Mitral valvuloplasty (MVP) appears to be associated with superior postoperative survival compared to mitral valve replacement (MVR) in ANMIE.
  • MVP is a desirable and potentially more durable alternative to MVR when feasible.
  • Further powered clinical trials are necessary to confirm these findings, considering patient characteristics and surgeon preferences.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
271
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
335
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
407
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
736
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
561
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
422